company background image
PRO

Societe de Promotion Pharmaceutique du Maghreb CBSE:PRO Stock Report

Last Price

د.م893.00

Market Cap

د.م893.0m

7D

0%

1Y

-20.4%

Updated

27 Nov, 2022

Data

Company Financials
PRO fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends2/6

PRO Stock Overview

Societe de Promotion Pharmaceutique du Maghreb S.A.

Societe de Promotion Pharmaceutique du Maghreb S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Societe de Promotion Pharmaceutique du Maghreb
Historical stock prices
Current Share Priceد.م893.00
52 Week Highد.م1,226.00
52 Week Lowد.م893.00
Beta0.15
1 Month Change-10.70%
3 Month Changen/a
1 Year Change-20.41%
3 Year Change5.06%
5 Year Change-42.28%
Change since IPO-8.60%

Recent News & Updates

Recent updates

Shareholder Returns

PROMA PharmaceuticalsMA Market
7D0%-2.3%-0.06%
1Y-20.4%-22.3%-17.9%

Return vs Industry: PRO exceeded the MA Pharmaceuticals industry which returned -22.3% over the past year.

Return vs Market: PRO underperformed the MA Market which returned -17.9% over the past year.

Price Volatility

Is PRO's price volatile compared to industry and market?
PRO volatility
PRO Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement4.3%
Market Average Movement4.5%
10% most volatile stocks in MA Market6.2%
10% least volatile stocks in MA Market3.1%

Stable Share Price: Insufficient data to determine PRO's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine PRO's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1947n/aMa'mon Salameh Alaraidehhttps://www.promopharm.co.ma

Societe de Promotion Pharmaceutique du Maghreb S.A. produces, commercializes, imports, and exports medicines, derma-pharmaceuticals, and cosmetic products in Africa. It also subcontracts medicines for national and international laboratories. The company was founded in 1947 and is headquartered in Had-Soualem, Morocco.

Societe de Promotion Pharmaceutique du Maghreb S.A. Fundamentals Summary

How do Societe de Promotion Pharmaceutique du Maghreb's earnings and revenue compare to its market cap?
PRO fundamental statistics
Market Capد.م893.00m
Earnings (TTM)د.م72.33m
Revenue (TTM)د.م671.00m

12.3x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PRO income statement (TTM)
Revenueد.م671.00m
Cost of Revenueد.م324.05m
Gross Profitد.م346.95m
Other Expensesد.م274.63m
Earningsد.م72.33m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)72.33
Gross Margin51.71%
Net Profit Margin10.78%
Debt/Equity Ratio10.2%

How did PRO perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

55%

Payout Ratio